Mehta Analysis: Who Will Speak Out As Regulators Are Politicized?
FDA Leadership Moves, China-US Trade Spat And Brexit Threaten Sector
In his latest opinion piece, Viren Mehta fears the impact that ideologically motivated and protectionist actions around the world will have on the biopharma sector and ultimately on patients.
